Cancers | Free Full-Text | Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response | HTML
Engineering the perfect (bacterial) cancer therapy | Nature Reviews Cancer
Newly Discovered Mechanism Helps Our Own Immune Systems Fight Cancer
Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism | Nature Communications
Frontiers | Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential | Endocrinology
Patient-derived explants (PDEs) as a powerful preclinical platform for anti- cancer drug and biomarker discovery | British Journal of Cancer
First description of ultramutated endometrial cancer caused by germline loss-of-function and somatic exonuclease domain mutations in POLE gene
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity | Nature Communications
Interpreting pathways to discover cancer driver genes with Moonlight | Nature Communications
Forbes Publishes in Nature Reviews | College of Engineering | UMass Amherst
Breast cancer | Nature Reviews Disease Primers
Detailed modeling of positive selection improves detection of cancer driver genes | Nature Communications
P53: The Gene That Cracked the Cancer Code by Sue Armstrong – review | Science and nature books | The Guardian
New Partnership Could Eventually Lead To 'One-Size-Fits-All' Cancer Vaccines
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma | Nature Communications
Frontiers | PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer | Oncology
Cells of origin in cancer | Nature
Cancers | Free Full-Text | Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer | HTML
Cancer immunotherapy - Wikipedia
Frontiers | Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy | Cell and Developmental Biology
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening | Nature Communications
Natural killer cells in cancer biology and therapy | Molecular Cancer | Full Text
An analysis of genetic heterogeneity in untreated cancers | Nature Reviews Cancer
